Seed Therapeutics
Company

Seed Therapeutics

Biotechnology Research 28 Liberty St 20 employees
Employees
20
Contacts
4
Emails
4
Phones
2

Seed Therapeutics Overview

Headquarters
28 Liberty St
Industry
Biotechnology Research
Employees
20
Funding
24.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Seed Therapeutics

Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.” Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success. Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients.

Seed Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Seed Therapeutics Org Chart

Sample employees and titles
Name Title Contact
James Tonra, Phd President and Chief Scientific Officer at Seed Therapeutics
Email Phone
Bill Desmarais
Email Phone
Fei Liu Director of Biology and Discovery at Seed Therapeutics
Email
James Finn Senior Director of Operations at Seed Therapeutics
Email

Employees by Management Level

Director 2 profiles
Executive 1 profile

Compare Similar Companies to Seed Therapeutics